Fatigue and Chemotherapy

• NT Factor® reduced fatigue in 57 to 70 percent of cancer patients
• Improved other adverse effects of cancer therapy

Nutritional support with NT Factor and antioxidants offers hope for overcoming the most prevalent and disabling side effect of cancer therapy: fatigue. Over 75 percent of cancer patients experience fatigue as a side effect of chemotherapy, although only 32 percent of treating physicians recognize this problem. However, both patients and physicians recognize that fatigue is a more common problem than pain during cancer therapy, and a significant reason why patients discontinue therapy.

While there has been little progress in reducing this debilitating condition during cancer treatment, research shows that NT Factor plus antioxidants have reduced fatigue in 57 to 70 percent of cancer patients. The same nutritional combination has also improved other adverse effects of cancer therapy, such as pain, nausea, vomiting, malaise, diarrhea, headaches, rashes and infections.

Nicolson GL, Lipid Replacement/Antioxidant Therapy as an Adjunct Supplement to Reduce the Adverse Effects of Cancer Therapy and Restore Mitochondrial Function, Pathology Oncology Research 2005 11(3):139-144.
View abstract: